SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rae-Grant, A. D
Right arrow Articles by Reed, J. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rae-Grant, A. D
Right arrow Articles by Reed, J. F
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity

Alex D Rae-Grant

Division of neurology and research department, Lehigh Valley Hospital, Allentown, Pennsylvania, USA

Nancy J Eckert

Division of neurology and research department, Lehigh Valley Hospital, Allentown, Pennsylvania, USA

Sharon Bartz

Division of neurology and research department, Lehigh Valley Hospital, Allentown, Pennsylvania, USA

James F Reed

Division of neurology and research department, Lehigh Valley Hospital, Allentown, Pennsylvania, USA

Objective: To assess the frequency and quality of sensory symptoms in a population of patients with Multiple Sclerosis (MS) and compare them with controls. Design: Survey to target population and control group evaluating demographic data, data on disease course, presence of various symptoms of MS. Setting: Neurological practices affiliated with a tertiary community hospital. Participants: 224 patients with MS, 93 controls of similar age and sex. Results: Sensory symptoms were more common in MS patients than in controls, and differed in severity and quality. Fifty per cent described brief (seconds to hours) episodes of neurological dysfunction, significantly more often than in controls (P=0.001). Pain was present at some time in similar percentages in patients and controls, but active pain problems were present more often in MS patients (P=0.001). The qualitative description of pain in MS patients was more often neuropathic, with burning, itching, electric and formicatory pain, as opposed to throbbing, sharp or muscular pain. Pain was localized to arms, legs, trunk, hands, feet and face more often in the MS group. Lhermitte's phenomenon was present in two-thirds of patients at some time in their disease course. Twenty per cent of the patients identified themselves as having respiratory problems (Controls 7.5%, P=0.005). Fatigue limited activity in 78% of patients, but only in 17% of controls (P=0.001). Dizziness, memory dysfunction, and restless legs symptoms were all more frequent in patients. The self-rated `worst' symptoms of MS was pain in 12%, fatigue in 17% and dizziness in 5%, a total of 34% of `worst' symptoms. Sensory symptoms were present in patients with early disease and without disability as often as in disabled patients and in those with longer disease duration. There was however a strong correlation between the total number of sensory symptoms reported and the presence of disability in the MS patients. Conclusions: Sensory symptoms are common in MS patients. Pain syndromes, transient neurologic events, Lhermitte's phenomenon, fatigue, respiratory symptoms and vertigo were present significantly more frequently in patients with MS than in a control population and contributed to subjective morbidity. Future clinical trials assessing therapy in MS might include sensory symptoms as secondary endpoints to capture this `hidden reservoir' of disease morbidity.

Key Words: multiple sclerosis • pain • headache • fatigue • respiration • sensation • Lhermitte's • vertigo

Multiple Sclerosis, Vol. 5, No. 3, 179-183 (1999)
DOI: 10.1177/135245859900500307


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
J. F. Foley and D. W. Brandes
Redefining functionality and treatment efficacy in multiple sclerosis
Neurology, June 9, 2009; 72(23_Supplement_5): S1 - S11.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
F Martinelli Boneschi, B Colombo, P Annovazzi, V Martinelli, L Bernasconi, C Solaro, and G Comi
Lifetime and actual prevalence of pain and headache in multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 514 - 521.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Manconi, M.A. Rocca, L. Ferini-Strambi, P. Tortorella, F. Agosta, G. Comi, and M. Filippi
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage
Multiple Sclerosis, January 1, 2008; 14(1): 86 - 93.
[Abstract] [PDF]


Home page
Mult SclerHome page
D M Ehde, T L Osborne, M A Hanley, M P Jensen, and G H Kraft
The scope and nature of pain in persons with multiple sclerosis
Multiple Sclerosis, September 1, 2006; 12(5): 629 - 638.
[Abstract] [PDF]


Home page
StrokeHome page
H. Naess, U. Waje-Andreassen, L. Thomassen, H. Nyland, and K.-M. Myhr
Health-Related Quality of Life Among Young Adults With Ischemic Stroke on Long-Term Follow-Up
Stroke, May 1, 2006; 37(5): 1232 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A. H Al-Araji and J. Oger
Reappraisal of Lhermitte's sign in multiple sclerosis
Multiple Sclerosis, August 1, 2005; 11(4): 398 - 402.
[Abstract] [PDF]


Home page
Mult SclerHome page
L. V Kalia and P. W OConnor
Severity of chronic pain and its relationship to quality of life in multiple sclerosis
Multiple Sclerosis, June 1, 2005; 11(3): 322 - 327.
[Abstract] [PDF]


Home page
J. Immunol.Home page
A. K. Wensky, G. C. Furtado, M. C. Garibaldi Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille
IFN-{gamma} Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis
J. Immunol., February 1, 2005; 174(3): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
K. B Svendsen, T. S Jensen, and F. W Bach
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
BMJ, July 31, 2004; 329(7460): 253.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. M Ehde, L. E Gibbons, L. Chwastiak, C. H Bombardier, M. D Sullivan, and G. H Kraft
Chronic pain in a large community sample of persons with multiple sclerosis
Multiple Sclerosis, December 1, 2003; 9(6): 605 - 611.
[Abstract] [PDF]


Home page
Mult SclerHome page
I Siev-Ner, D Gamus, L Lerner-Geva, and A Achiron
Refiexology treatment relieves symptoms of multiple sclerosis: a randomized controlled study
Multiple Sclerosis, August 1, 2003; 9(4): 356 - 361.
[Abstract] [PDF]


Home page
Arch NeurolHome page
K. B. Svendsen, T. S. Jensen, K. Overvad, H. J. Hansen, N. Koch-Henriksen, and F. W. Bach
Pain in Patients With Multiple Sclerosis: A Population-Based Study
Arch Neurol, August 1, 2003; 60(8): 1089 - 1094.
[Abstract] [Full Text] [PDF]



Advertisement